Oncospace— 510(k) K202284

Substantially Equivalent

Oncospace, Inc.

FDA 510(k) clearance K202284 for Oncospace, Substantially Equivalent on 2021-03-12. Applicant: Oncospace, Inc..

Clearance details

Applicant: Oncospace, Inc.
Product code: Code MUJ
Advisory panel: Radiology
Date received: 2020-08-12
Decision date: 2021-03-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Baltimore, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.